What is Relation Therapeutics?
Founded in 2019, Relation Therapeutics is at the forefront of end-to-end biotech development, utilizing cutting-edge technology to unravel complex human biology. The company's core mission is to discover therapies for life-threatening conditions by leveraging single-cell and multi-omics measurements from patient tissue, advanced functional assays, and sophisticated machine learning algorithms. This data-driven methodology aims to provide an unprecedented understanding of disease mechanisms, paving the way for more effective treatments from cause to cure.
How much funding has Relation Therapeutics raised?
Relation Therapeutics has raised a total of $86M across 2 funding rounds:
Angel/Seed
$60M
Other Financing Round
$26M
Angel/Seed (2024): $60M with participation from DCVC, NVentures, Magnetic Ventures, and Khosla Ventures
Other Financing Round (2025): $26M led by DCVC Management, Magnetic Ventures, and NVIDIA
Key Investors in Relation Therapeutics
DCVC
DCVC is a deep tech venture capital firm that invests in entrepreneurs tackling some of the world's most challenging problems, with a focus on leveraging artificial intelligence across sectors like biotechnology.
NVentures
NVentures is an upstream exploration firm providing intelligence for the E&P and Energy industry, with a growing focus on hydrogen and renewable energy opportunities.
Magnetic Ventures
Magnetic Ventures is a female-founded venture capital firm specializing in early-stage healthcare innovation, leveraging AI, machine learning, and next-gen biotech.
What's next for Relation Therapeutics?
The substantial enterprise-level capital infusion positions Relation Therapeutics for accelerated growth and the scaling of its research and development initiatives. This strategic backing is expected to fuel the expansion of its technological platforms and the advancement of its therapeutic pipeline. With a focus on deep technology and a commitment to tackling some of the most challenging diseases, Relation Therapeutics is poised to make significant contributions to the biotechnology sector, potentially leading to breakthroughs in patient care and medical innovation.
See full Relation Therapeutics company page
